Fri. Jun 14th, 2024
FDA cautions that widely used pain-relief creams could present serious health hazards

Recently, the U.S. Food and Drug Administration (FDA) has issued a warning to six companies that sell unapproved and misbranded over-the-counter topical pain-relief products containing higher-than-allowed concentrations of lidocaine, a local anesthetic. Jill Furman, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research, emphasized the risks associated with these products, stating that they should not be on the market due to the potential harm they pose to consumers.

The problem with these products lies in their excessive lidocaine content, which can lead to serious side effects such as irregular heartbeat, seizures, and breathing difficulties, especially when used on a large area of skin or irritated skin. To prevent adverse effects, the FDA recommends avoiding products containing more than 4% lidocaine, refraining from usage on large areas of skin, and avoiding wrapping the product with dressings or plastic wraps.

Some of the products cited by the FDA in their warning include TKTX Numb Maximum Strength Pain Reliever, NumbSkin Lidocaine Numbing Creams, and Signature Tattoo Numbing Cream. It is essential to heed these warnings to protect your health and well-being while undergoing cosmetic procedures. For more detailed information on the specific products mentioned in the FDA’s warning, interested individuals can refer to the FDA’s official press release.

By Aiden Nguyen

As a content writer at newscholarly.com, I delve into the realms of storytelling with the power of words. With a knack for research and a passion for crafting compelling narratives, I strive to bring forth engaging and informative articles for our readers. From decoding complex concepts to unraveling current events, I aim to captivate and educate through the art of writing. Join me on this journey as we explore the ever-evolving landscape of news and knowledge together.

Leave a Reply